SCHEMBL9529200

SCHEMBL9529200

CCCCC(OC)(OC)c1nc(CCC(C)C)n(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)n1

nearest known ligand 0.44

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 6/20 0.44
AGTR2 P50052 6/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9529508 0.95 AGTR1 (0.42) AGTR1AGTR2
SCHEMBL9529542 0.93 AGTR1 (0.51) AGTR1AGTR2
SCHEMBL9528403 0.93 AGTR1 (0.47) AGTR1AGTR2
SCHEMBL9529698 0.92 AGTR1 (0.42) AGTR1AGTR2
SCHEMBL9527640 0.92 AGTR1 (0.49) AGTR1AGTR2
SCHEMBL9531032 0.92 AGTR1 (0.39) AGTR1AGTR2
SCHEMBL9528759 0.90 AGTR1 (0.44) AGTR1AGTR2
SCHEMBL8103532 0.90 AGTR1 (0.46) AGTR1AGTR2
SCHEMBL8105087 0.90 AGTR1 (0.51) AGTR1AGTR2
SCHEMBL9529652 0.89 AGTR1 (0.49) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed